AbbVie Net Worth 2010-2018 | ABBV

Interactive chart of historical net worth (market cap) for AbbVie (ABBV) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AbbVie net worth as of February 21, 2019 is $120.32B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $120.322B $32.753B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $365.814B 16.67
Pfizer (PFE) United States $251.211B 14.07
Merck (MRK) United States $214.158B 18.30
Novartis AG (NVS) Switzerland $209.609B 17.83
Eli Lilly (LLY) United States $127.004B 22.06
Novo Nordisk (NVO) Denmark $121.443B 19.64
Sanofi (SNY) France $105.716B 13.05
AstraZeneca (AZN) United Kingdom $102.658B 11.71
GlaxoSmithKline (GSK) United Kingdom $102.598B 13.47
Bristol-Myers Squibb (BMY) United States $83.732B 12.89